Page 364 - Haematologica Vol. 109 - July 2024

ERRATUM
Erratum to: Ultra-deep mutational landscape in chronic lymphocytic leukemia uncovers dynamics of resistance to targeted therapies
David W. Woolston,1* Nathan D. Lee,2* Mazyar Shadman,1,2* Elena Latorre-Esteves,2 Xin Ray Tee,2 Jeanne Fredrickson,2 Brendan F. Kohrn,2 Chaitra Ujjani,1,2 Ashley Eckel,2 Brian Till,1,2 Min Fang,1,2 Jerald Radich,1,2 Ivana Bozic,1,2# Rosa Ana Risques2# and Cecilia C.S. Yeung1,2#
1Fred Hutchinson Cancer Center and 2University of Washington, Seattle, WA, USA
*DWW, NDL, and MS contributed equally as first authors. #IB, RAR, and CCSY contributed equally as senior authors.
On page 837 of the article by Woolston et al.,1 in the sentence reproduced below, “ibrutinib” should be replaced with “acalabrutinib”:
Incorrect sentence:
“Sample R002-A was collected after 3 months of combination therapy with ibrutinib and venetoclax.”
Correct sentence:
“Sample R002-A was collected after 3 months of combination therapy with acalabrutinib and venetoclax.”
References
1. Woolston DW, Lee ND, Shadman M, et al. Ultra-deep mutational landscape in chronic lymphocytic leukemia uncovers dynamics of resistance to targeted therapies. Haematologica. 2024;109(3):835-845.
Haematologica | 109 July 2024
2378
Correspondence: C.S. Yeung_Cecilia cyeung@fredhutch.org
Received: January 25, 2024. Accepted: January 25, 2024.
https://doi.org/10.3324/haematol.2024.285151
©2024 Ferrata Storti Foundation Published under a CC BY-NC license